Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a slight decline, with a closing price of 131.93 yuan on January 20, 2026, down by 1.81% [1] Financial Performance - For the first three quarters of 2025, United Imaging Healthcare reported a main revenue of 8.859 billion yuan, an increase of 27.39% year-on-year [2] - The net profit attributable to shareholders reached 1.12 billion yuan, up by 66.91% year-on-year [2] - The non-recurring net profit was 1.053 billion yuan, reflecting a significant increase of 126.94% year-on-year [2] - In Q3 2025 alone, the company achieved a main revenue of 2.843 billion yuan, a remarkable rise of 75.41% year-on-year [2] - The net profit for Q3 2025 was 122 million yuan, showing an increase of 143.8% year-on-year [2] - The non-recurring net profit for Q3 2025 was 87.6141 million yuan, up by 126.24% year-on-year [2] - The company's debt ratio stands at 30.08%, with investment income of 606.847 million yuan and financial expenses of -438.233 million yuan [2] - The gross profit margin is reported at 47.02% [2] Market Activity - On January 20, 2026, the net inflow of main funds was 18.2237 million yuan, accounting for 1.53% of the total transaction amount [1] - Retail investors experienced a net outflow of 1.5584 million yuan, representing 0.13% of the total transaction amount [1] - Over the past 90 days, 25 institutions have rated the stock, with 18 buy ratings and 7 hold ratings [2] - The average target price set by institutions over the past 90 days is 17.635 billion yuan [2]
股票行情快报:联影医疗(688271)1月20日主力资金净买入1822.37万元